1. Home
  2. Flashcards
  3. Preview

PHRD5915 Drug Design - Winston Lectures Review

  1. pharmacokinetic phase of drug action
    ADME
  2. pharmacodynamic phase of drug action
    pharmacological & toxicological effects (interactions w/ biological targets)
  3. how most drugs pass through lipid membranes for absorption & distribution to occur
    passive diffusion
  4. 2 requirements for most drugs to pass through lipid membranes
    • 1) drugs must have lipophilicity
    • 2) concentration gradient
  5. faces outside of lipid bilayers
    polar, hydrophilic heads
  6. faces inside of lipid bilayers
    nonpolar, hydrophobic fatty acid tails
  7. saturated or unsaturated tails increase fluidity
    unsaturated
  8. 4 factors controlling drug distribution
    • 1) size
    • 2) lipophilicity/hydrophilicity
    • 3) polarity
    • 4) ionic state (pKa)
  9. Image Upload 1
    imine
  10. toxic metabolite of APAP
    N-acetyl-p-benzoquinone imine (NAPQI)
  11. Image Upload 2
    phenol
  12. Image Upload 3
    ester
  13. Image Upload 4
    carbonyl
  14. Image Upload 5
    carboxylic acid
  15. Image Upload 6 or Image Upload 7
    aldehyde
  16. Image Upload 8
    ether
  17. Image Upload 9
    ketone
  18. Image Upload 11
    amide
  19. pH > pKa
    deprotonated
  20. pH < pKa
    protonated
  21. carboxylic acid + alcohol
    ester + H2O
  22. carboxylic acid + amine
    amide + H2O
  23. Image Upload 12
    thiol

    (important fcnal group in cysteine)
  24. Image Upload 14
    sulfide
  25. Image Upload 16
    sulfoxide
  26. Image Upload 18
    sulfone
  27. Image Upload 20
    sulfonic acid
  28. Henderson-Hasselbalch Equation
    pH = pKa - log([HA]/[A-])
  29. [A-] > [HA]
    non-ionized
  30. e- withdrawing groups in R ____ (raise/lower) pKa
    lower

    (weaken the base)
  31. e- donating groups in R ____ (raise/lower) pKa
    raise

    (make a stronger base)
  32. substrate binds close to P450 heme. spectrum?
    Type 1 

    (high @ 410nm)
  33. substrate binds directly to P450 heme. spectrum?
    Type II

    (high @ 440nm)
  34. where does P450 get its electrons?
    from NADPH via CYP450 reductase
  35. biotransformation
    changes properties of a xenobiotic from lipophilic to hydrophilic
  36. characteristics of Phase I products (2)
    • 1) inactivation
    • 2) conversion of active drug to another active one
  37. example of Phase 1 conversion of an active drug to another active drug
    codeine, heroine -> morphine
  38. 4 compartments alcohol detoxification takes place in
    • 1) microsomes (CYP2E1)
    • 2) cytosol (ADH)
    • 3) mitochondria (ALDH)
    • 4) peroxisomes (catalase)
  39. products of CCl4 breakdown (4)
    • 1) carbon monoxide
    • 2) carbon dioxide
    • 3) phosgene
    • 4) HCl
  40. coupling of reduction of H2O2 & lipid hydroperoxides to the oxidation of other substances
    cooxidation

    (used by peroxidases, instead of using NADPH or NADH)
  41. universal sulfonate donor for all sulfotransferase reactions
    PAPS (3'phosphoadenosine-5'phosphosulfate)
  42. APS + ATP =
    PAPS

    (sulfation reaction)
  43. sulfotransferase + PAPS =
    PAP
Author
daynuhmay
ID
265403
Card Set
PHRD5915 Drug Design - Winston Lectures Review
Description
drug design
Updated

  1. Home
  2. Flashcards
  3. Preview